$VTAE Vitae Pharmaceuticals, Inc Insider Trading Week 43/2016
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Vitae Pharmaceuticals, Inc.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Vitae Pharmaceuticals, Inc in week 43/2016.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 25 2016 | VTAE | Vitae Pharmaceutic ... | Gregg Richard | Chief Science Offic ... | Option Exercise | D | 8.78 | 16,500 | 144,870 | 0 | |
| Oct 25 2016 | VTAE | Vitae Pharmaceutic ... | Gregg Richard | Chief Science Offic ... | Option Exercise | D | 8.58 | 32,750 | 280,995 | 0 | |
| Oct 25 2016 | VTAE | Vitae Pharmaceutic ... | Gregg Richard | Chief Science Offic ... | Option Exercise | D | 8.28 | 21,250 | 175,950 | 0 | |
| Oct 25 2016 | VTAE | Vitae Pharmaceutic ... | Gregg Richard | Chief Science Offic ... | Option Exercise | D | 14.40 | 14,306 | 206,006 | 0 | |
| Oct 25 2016 | VTAE | Vitae Pharmaceutic ... | Gregg Richard | Chief Science Offic ... | Option Exercise | D | 7.13 | 21,647 | 154,343 | 0 | |
| Oct 25 2016 | VTAE | Vitae Pharmaceutic ... | Gregg Richard | Chief Science Offic ... | Sell | D | 21.00 | 228,274 | 4,793,754 | 228,274 | 456.5 K to 228.3 K (-50.00 %) |
| Oct 25 2016 | VTAE | Vitae Pharmaceutic ... | Rowland Charles A Jr | Director | Option Exercise | D | 9.62 | 10,000 | 96,200 | 0 | |
| Oct 25 2016 | VTAE | Vitae Pharmaceutic ... | Rowland Charles A Jr | Director | Option Exercise | D | 12.43 | 10,000 | 124,300 | 0 | |
| Oct 25 2016 | VTAE | Vitae Pharmaceutic ... | Rowland Charles A Jr | Director | Option Exercise | D | 8.00 | 17,000 | 136,000 | 0 | |
| Oct 25 2016 | VTAE | Vitae Pharmaceutic ... | LEONARD JOHN M. | Director | Option Exercise | D | 9.62 | 10,000 | 96,200 | 0 | |
| Oct 25 2016 | VTAE | Vitae Pharmaceutic ... | LEONARD JOHN M. | Director | Option Exercise | D | 9.85 | 20,000 | 197,000 | 0 | |
| Oct 25 2016 | VTAE | Vitae Pharmaceutic ... | Gunderson Robert V JR | Director | Option Exercise | D | 9.62 | 10,000 | 96,200 | 0 | |
| Oct 25 2016 | VTAE | Vitae Pharmaceutic ... | Gunderson Robert V JR | Director | Option Exercise | D | 12.43 | 10,000 | 124,300 | 0 | |
| Oct 25 2016 | VTAE | Vitae Pharmaceutic ... | Gunderson Robert V JR | Director | Option Exercise | D | 8.00 | 17,000 | 136,000 | 0 | |
| Oct 25 2016 | VTAE | Vitae Pharmaceutic ... | Gunderson Robert V JR | Director | Option Exercise | D | 5.29 | 9,091 | 48,091 | 0 | |
| Oct 25 2016 | VTAE | Vitae Pharmaceutic ... | Gunderson Robert V JR | Director | Option Exercise | D | 3.91 | 5,434 | 21,247 | 0 | |
| Oct 25 2016 | VTAE | Vitae Pharmaceutic ... | Gunderson Robert V JR | Director | Sell | U | 21.00 | 15,830 | 332,430 | 0 | 15.8 K to 0 (-100.00 %) |
| Oct 25 2016 | VTAE | Vitae Pharmaceutic ... | Gunderson Robert V JR | Director | Sell | U | 21.00 | 11,002 | 231,042 | 0 | 11 K to 0 (-100.00 %) |
| Oct 25 2016 | VTAE | Vitae Pharmaceutic ... | Sable Carole | Chief Medical Offic ... | Option Exercise | D | 10.51 | 150,000 | 1,576,500 | 0 | |
| Oct 25 2016 | VTAE | Vitae Pharmaceutic ... | Hatfield Jeffrey S. | Chief Executive Off ... | Option Exercise | D | 8.78 | 60,000 | 526,800 | 0 | |
| Oct 25 2016 | VTAE | Vitae Pharmaceutic ... | Hatfield Jeffrey S. | Chief Executive Off ... | Option Exercise | D | 8.58 | 60,000 | 514,800 | 0 | |
| Oct 25 2016 | VTAE | Vitae Pharmaceutic ... | Hatfield Jeffrey S. | Chief Executive Off ... | Option Exercise | D | 8.28 | 50,000 | 414,000 | 0 | |
| Oct 25 2016 | VTAE | Vitae Pharmaceutic ... | Hatfield Jeffrey S. | Chief Executive Off ... | Option Exercise | D | 14.40 | 50,000 | 720,000 | 0 | |
| Oct 25 2016 | VTAE | Vitae Pharmaceutic ... | Hatfield Jeffrey S. | Chief Executive Off ... | Option Exercise | D | 7.13 | 134,782 | 960,996 | 0 | |
| Oct 25 2016 | VTAE | Vitae Pharmaceutic ... | Hatfield Jeffrey S. | Chief Executive Off ... | Option Exercise | D | 6.90 | 10,320 | 71,208 | 0 | |
| Oct 25 2016 | VTAE | Vitae Pharmaceutic ... | Hatfield Jeffrey S. | Chief Executive Off ... | Option Exercise | D | 3.91 | 20,869 | 81,598 | 0 | |
| Oct 25 2016 | VTAE | Vitae Pharmaceutic ... | Hatfield Jeffrey S. | Chief Executive Off ... | Option Exercise | D | 3.91 | 6,245 | 24,418 | 0 | |
| Oct 25 2016 | VTAE | Vitae Pharmaceutic ... | Hatfield Jeffrey S. | Chief Executive Off ... | Option Exercise | D | 3.45 | 30,434 | 104,997 | 0 | |
| Oct 25 2016 | VTAE | Vitae Pharmaceutic ... | Hatfield Jeffrey S. | Chief Executive Off ... | Option Exercise | D | 3.45 | 26,086 | 89,997 | 0 | |
| Oct 25 2016 | VTAE | Vitae Pharmaceutic ... | Hatfield Jeffrey S. | Chief Executive Off ... | Sell | U | 21.00 | 244,996 | 5,144,916 | 244,996 | 490 K to 245 K (-50.00 %) |
| Oct 25 2016 | VTAE | Vitae Pharmaceutic ... | HAYDEN DONALD J JR | Director | Option Exercise | D | 9.62 | 10,000 | 96,200 | 0 | |
| Oct 25 2016 | VTAE | Vitae Pharmaceutic ... | HAYDEN DONALD J JR | Director | Option Exercise | D | 12.43 | 10,000 | 124,300 | 0 | |
| Oct 25 2016 | VTAE | Vitae Pharmaceutic ... | HAYDEN DONALD J JR | Director | Option Exercise | D | 8.00 | 17,000 | 136,000 | 0 | |
| Oct 25 2016 | VTAE | Vitae Pharmaceutic ... | HAYDEN DONALD J JR | Director | Option Exercise | D | 5.29 | 18,182 | 96,183 | 0 | |
| Oct 25 2016 | VTAE | Vitae Pharmaceutic ... | JUNIUS DANIEL M | Director | Option Exercise | D | 11.37 | 20,000 | 227,400 | 0 | |
| Oct 25 2016 | VTAE | Vitae Pharmaceutic ... | Bernstein Karen | Director | Option Exercise | D | 9.62 | 10,000 | 96,200 | 0 | |
| Oct 25 2016 | VTAE | Vitae Pharmaceutic ... | Bernstein Karen | Director | Option Exercise | D | 11.01 | 20,000 | 220,200 | 0 | |
| Oct 25 2016 | VTAE | Vitae Pharmaceutic ... | Fratamico Arthur | Chief Business Offi ... | Option Exercise | D | 8.78 | 14,500 | 127,310 | 0 | |
| Oct 25 2016 | VTAE | Vitae Pharmaceutic ... | Fratamico Arthur | Chief Business Offi ... | Option Exercise | D | 8.58 | 19,250 | 165,165 | 0 | |
| Oct 25 2016 | VTAE | Vitae Pharmaceutic ... | Fratamico Arthur | Chief Business Offi ... | Option Exercise | D | 8.28 | 13,750 | 113,850 | 0 | |
| Oct 25 2016 | VTAE | Vitae Pharmaceutic ... | Fratamico Arthur | Chief Business Offi ... | Option Exercise | D | 14.40 | 13,750 | 198,000 | 0 | |
| Oct 25 2016 | VTAE | Vitae Pharmaceutic ... | Fratamico Arthur | Chief Business Offi ... | Option Exercise | D | 5.29 | 152,173 | 804,995 | 0 | |
| Oct 25 2016 | VTAE | Vitae Pharmaceutic ... | Fratamico Arthur | Chief Business Offi ... | Sell | U | 21.00 | 13,233 | 277,893 | 0 | 13.2 K to 0 (-100.00 %) |
| Oct 25 2016 | VTAE | Vitae Pharmaceutic ... | SANTINI GINO | Director | Option Exercise | D | 9.62 | 10,000 | 96,200 | 0 | |
| Oct 25 2016 | VTAE | Vitae Pharmaceutic ... | SANTINI GINO | Director | Option Exercise | D | 12.43 | 10,000 | 124,300 | 0 | |
| Oct 25 2016 | VTAE | Vitae Pharmaceutic ... | SANTINI GINO | Director | Option Exercise | D | 8.00 | 17,000 | 136,000 | 0 | |
| Oct 25 2016 | VTAE | Vitae Pharmaceutic ... | Morris Richard Steven | Chief Financial Off ... | Option Exercise | D | 8.78 | 27,500 | 241,450 | 0 | |
| Oct 25 2016 | VTAE | Vitae Pharmaceutic ... | Morris Richard Steven | Chief Financial Off ... | Option Exercise | D | 8.58 | 27,500 | 235,950 | 0 | |
| Oct 25 2016 | VTAE | Vitae Pharmaceutic ... | Morris Richard Steven | Chief Financial Off ... | Option Exercise | D | 8.28 | 15,000 | 124,200 | 0 | |
| Oct 25 2016 | VTAE | Vitae Pharmaceutic ... | Morris Richard Steven | Chief Financial Off ... | Option Exercise | D | 14.40 | 15,000 | 216,000 | 0 | |
| Oct 25 2016 | VTAE | Vitae Pharmaceutic ... | Morris Richard Steven | Chief Financial Off ... | Option Exercise | D | 5.29 | 152,173 | 804,995 | 0 | |
| Oct 25 2016 | VTAE | Vitae Pharmaceutic ... | Morris Richard Steven | Chief Financial Off ... | Sell | D | 21.00 | 828 | 17,388 | 0 | 828 to 0 (-100.00 %) |
| Oct 25 2016 | VTAE | Vitae Pharmaceutic ... | Applebaum Scott | General Counsel | Option Exercise | D | 8.75 | 150,000 | 1,312,500 | 0 |